Clinical Trial Update: The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study [Phase 3]

View source ↗

Summary

Phase 3 clinical trial exploring the dosing knowledge of CDK4/6 inhibitors in metastatic breast cancer; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: American Society of Clinical Oncology | Conditions: Metastatic Breast Cancer | Phase 3 | Status: RECRUITING